GRANTS. The Sjöberg Foundation has awarded SEK 15 million to four cancer researchers at the University of Gothenburg: Roger Olofsson Bagge, Anders Ståhlberg, Barbro Linderholm, and Lisa Tuomi. The research will improve treatment for patients with ocular melanoma, sarcoma, breast cancer, and cancers of the head and neck. The Sjöberg Foundation has announced the award of grants totaling SEK 53.1 million, of which SEK 15 million goes to four cancer…
Successful treatment in mice for severe childhood cancer
NEW STUDY. In mice with high-risk neuroblastoma, tumors disappeared in response to a new combination treatment with precision medicines, a recent study from University of Gothenburg researchers shows. This is a vital step toward a potentially curative treatment for a form of cancer affecting young children that is currently difficult to treat. The study, published in the journal Nature Communications, is the result of collaboration between researchers from the Universities…
Increased survival with eye melanoma in clinical trial
NEW STUDY. Once it has spread (metastasized), uveal (intraocular or eye) melanoma — an unusual form of cancer — has a very high mortality rate. In a study published in Nature Communications, researchers and doctors at the University of Gothenburg and Sahlgrenska University Hospital show that, in a small group of patients with metastatic uveal melanoma, a new combination treatment can bring about tumor shrinkage and prolonged survival. Uveal melanoma,…
The recipients of the 2021 Assar Gabrielsson’s Award announced
PRIZE RECIPIENTS. The Assar Gabrielsson Foundation’s Award goes to Sanhita Mitra in the category basic scientific research and to Maria Lycke in the category clinical cancer research. The recipients, both researchers at the University of Gothenburg, receive SEK 100,000 each, paid to Sahlgrenska Academy at the University of Gothenburg as an extra research grant. In the prize motivation, Professor Eva Forssell-Aronsson at the University of Gothenburg and executive member of…
New marker predicts benefit of radiotherapy for early-stage breast cancer
NEW STUDY. A study involving researchers at University of Gothenburg and Karolinska Institutet in Sweden has found that low levels of a protein called PDGFRb are associated with particularly good results of radiotherapy in women with early-stage breast cancer. The study, which is published in the journal Clinical Cancer Research, also suggests that the efficacy of radiotherapy can be improved with drugs that block this protein. Some 900 women in…